FLPIM
IOVA icon

F.L. Putnam Investment Management’s Iovance Biotherapeutics IOVA Stock Holding History

F.L. Putnam Investment Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$108K Hold
25,950
– – ﹤0.01% 640
2026
Q1 		$91.1K Hold
25,950
– – ﹤0.01% 565
2025
Q4 		$70.8K Buy
25,950
+5,661
+28% +$13.1K ﹤0.01% 586
2025
Q3 		$44K Buy
20,289
+5,300
+35% +$12.5K ﹤0.01% 576
2025
Q2 		$25.8K Buy
14,989
+3,789
+34% +$9.43K ﹤0.01% 580
2025
Q1 		$37.3K Buy
+11,200
New +$57.8K ﹤0.01% 564
2024
Q4 		– Sell
-240
Closed -$38.9K – 586
2024
Q3 		$38.9K Sell
240
-2,660
-92% -$25.2K ﹤0.01% 585
2024
Q2 		$23.3K Buy
+2,900
New +$31.1K ﹤0.01% 614

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

F.L. Putnam Investment Management's IOVA Position: Q2 2026 in Review

F.L. Putnam Investment Management held its Iovance Biotherapeutics (IOVA) position steady in Q2 2026 at 25,950 shares worth $108K. The position accounts for ﹤0.01% of the portfolio, ranked #640.

F.L. Putnam Investment Management first reported a position in IOVA in Q2 2024 and has held it in 8 quarters since. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • F.L. Putnam Investment Management held 25,950 shares of Iovance Biotherapeutics worth $108K as of Q2 2026.
  • F.L. Putnam Investment Management left its Iovance Biotherapeutics share count unchanged in Q2 2026.
  • Iovance Biotherapeutics made up ﹤0.01% of F.L. Putnam Investment Management's portfolio in Q2 2026, its #640 holding.
  • F.L. Putnam Investment Management first reported a position in Iovance Biotherapeutics in Q2 2024 and has held it in 8 quarters since.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on F.L. Putnam Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.